Mounjaro and infertility treatment
Medicine Mouniaro (tirzepatide) can make an important contribution to improving fertility in women whose infertility is related to obesity, insulin resistance or hormonal imbalance. As body mass and metabolic health have a strong influence on the functioning of the reproductive system, effective weight loss often plays a key role in restoring normal ovulation.
By reducing weight and improving insulin sensitivity, you can regulate the hormonal balancewhich allows for more regular menstrual cycles and the re-emergence of ovulation. As a result, many women are more likely to spontaneous conceptionsespecially in women who have not ovulated before or who have had irregular cycles.
For women undergoing treatment for infertility, treatment with Mounjar can also be an important preparation for assisted reproductive technology (ART) procedures. Weight loss is associated with better response to hormonal stimulation, higher egg quality and more successful fertility treatments.
In addition to improving the chances of getting pregnant, the treatment can also reduce the risk of pregnancy complications that are more common in obese women, such as gestational diabetes, hypertension and complications in early pregnancy.